## **Core Concept**
The treatment for CNS (Central Nervous System) leukemia involves targeting cancer cells that have infiltrated the central nervous system, which includes the brain and spinal cord. CNS leukemia is a complication that can occur in patients with acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML). Effective treatment requires medications that can cross the blood-brain barrier to reach therapeutic concentrations within the CNS.

## **Why the Correct Answer is Right**
The correct answer involves the use of **intrathecal chemotherapy** and/or **radiation therapy**. Intrathecal chemotherapy refers to the direct injection of chemotherapy drugs into the spinal fluid, allowing for high concentrations of the drug to come into contact with leukemia cells in the CNS while minimizing systemic side effects. Methotrexate, cytarabine, and dexamethasone are commonly administered intrathecally. Radiation therapy, specifically cranial irradiation, may also be used, especially in high-risk patients or those with evidence of CNS involvement.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not specify a recognized treatment modality for CNS leukemia. Without specifics, it's hard to directly refute, but generally, treatments involve chemotherapy, radiation, or a combination of both.
- **Option B:** This option is incorrect as it does not accurately represent a standard treatment approach for CNS leukemia. While systemic chemotherapy can play a role in treating leukemia, it is often insufficient on its own to treat CNS involvement due to the blood-brain barrier.
- **Option C:** This option might seem plausible but is incorrect if it suggests a treatment that is not standard for CNS leukemia. Supportive care alone is not sufficient for treating CNS leukemia.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **intrathecal methotrexate** is a cornerstone in the treatment and prophylaxis of CNS leukemia. Regular monitoring for CNS involvement is crucial in the management of leukemia patients, especially those with high-risk features. Early detection and treatment of CNS leukemia significantly improve outcomes.

## **Correct Answer:** . Methotrexate (intrathecal)